Tuberc Respir Dis.  2011 Sep;71(3):180-187.

The Efficacy of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Mediastinal Staging of Non-Small Cell Lung Cancer in a University Hospital

Affiliations
  • 1Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ccm@amc.seoul.kr
  • 2Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Abstract

BACKGROUND
In mediastinal lymph node sampling in non-small cell lung cancer (NSCLC) it is important to determine the appropriate treatment as well as to predict an outcome. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a recently developed, accurate, safe technique in patients with NSCLC for sampling mediastinal lymph nodes. We sought to determine the usefulness of EBUS-TBNA in mediastinal staging with NSCLC considered to be operable.
METHODS
We retrospectively reviewed the records of 142 patients who underwent EBUS-TBNA for mediastinal staging in the Asan Medical Center, Korea from July 2008 to July 2010. If patients were in an operable state, they underwent subsequent surgical staging. Diagnoses based on biopsy results were compared with those based on surgical results.
RESULTS
We performed EBUS-TBNA in 184 mediastinal lymph nodes in 142 NSCLC patients. Almost all of the EBUS-TBNA samples were from the lower paratracheal (112, 60.9%) and subcarinal (57, 31.0%) lymph nodes. In 142 patients, 51 patients (35.9%) were confirmed with malignant invasion of the mediastinal lymph node by EBUS-TBNA and 91 (64.1%) patients were not confirmed. Among the 91 patients, 64 patients (70.3%) underwent surgical staging. 3 patients (4.7%) who were misdiagnosed by the EBUS-TBNA were confirmed by surgery. After Diagnostic sensitivity of EBUS-TBNA, the prediction of mediastinal metastatsis was 94.4% and specificity was 100%. The procedures were performed safely and no serious complications were observed.
CONCLUSION
We demonstrated the high diagnostic value of EBUS-TBNA for mediastinal staging.

Keyword

Bronchi; Ultrasonography, Interventional; Biopsy, Fine-Needle; Mediastinum; Lymphatic Metastasis; Carcinoma, Non-Small-Cell Lung

MeSH Terms

Biopsy
Biopsy, Fine-Needle
Bronchi
Carcinoma, Non-Small-Cell Lung
Humans
Korea
Lymph Nodes
Lymphatic Metastasis
Mediastinum
Needles
Retrospective Studies
Ultrasonography, Interventional

Figure

  • Figure 1 Clinical course of 142 patients enrolled in the study. CTx: chemotherapy; EBUS-TBNA: endobronchial ultrasound-guided transbronchial needle aspiration; F/U: follow up; LN: lymph node; RTx: radiation therapy; mLN (+): tumor invade the mediastinal lymph node.

  • Figure 2 In a patient with right lower lobe (RLL) sarcomatoid carcinoma, nodal station 7 was assessed by EBUS-TBNA. (A) Axial CT image of stations 7. (B) EBUS image of station 7. EBUS-TBNA: endobronchial ultrasound-guided transbronchial needle aspiration; CT: computed tomography.

  • Figure 3 In a patient with left lower lobe (LLL) squamous cell carcinoma, nodal station 4L was assessed by EBUS-TBNA. (A) Axial CT image of stations 4L. (B) EBUS image of station 4L. EBUS-TBNA: endobronchial ultrasound-guided transbronchial needle aspiration; CT: computed tomography.

  • Figure 4 In a patient with Left lower lobe adenocarcinoma, nodal station 7 was assessed by EBUS-TBNA. (A) Axial CT image of stations 7. (B) EBUS image of station 7. EBUS-TBNA: endobronchial ultrasound-guided transbronchial needle aspiration; CT: computed tomography.


Reference

1. Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007. 132:3 Suppl. 178S–201S.
2. van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 2002. 359:1388–1393.
3. Higashi K, Ueda Y, Seki H, Yuasa K, Oguchi M, Noguchi T, et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med. 1998. 39:1016–1020.
4. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA. American College of Chest Physicians. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007. 132:3 Suppl. 202S–220S.
5. Navani N, Spiro SG, Janes SM. Mediastinal staging of NSCLC with endoscopic and endobronchial ultrasound. Nat Rev Clin Oncol. 2009. 6:278–286.
6. Adams K, Shah PL, Edmonds L, Lim E. Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax. 2009. 64:757–762.
7. Hwangbo B, Kim SK, Lee HS, Lee HS, Kim MS, Lee JM, et al. Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer. Chest. 2009. 135:1280–1287.
8. Lee HS, Lee GK, Lee HS, Kim MS, Lee JM, Kim HY, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest. 2008. 134:368–374.
9. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997. 111:1718–1723.
10. Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW. American College of Chest Physicians. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007. 132:3 Suppl. 243S–265S.
11. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, et al. Non-small cell lung cancer. J Natl Compr Canc Netw. 2010. 8:740–801.
12. Little AG, Rusch VW, Bonner JA, Gaspar LE, Green MR, Webb WR, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg. 2005. 80:2051–2056.
13. Lazzari Agli L, Trisolini R, Burzi M, Patelli M. Mediastinal hematoma following transbronchial needle aspiration. Chest. 2002. 122:1106–1107.
14. Herth F, Becker HD, Manegold C, Drings P. Endobronchial ultrasound (EBUS)--assessment of a new diagnostic tool in bronchoscopy for staging of lung cancer. Onkologie. 2001. 24:151–154.
15. Cameron SE, Andrade RS, Pambuccian SE. Endobronchial ultrasound-guided transbronchial needle aspiration cytology: a state of the art review. Cytopathology. 2010. 21:6–26.
16. Shannon JJ, Bude RO, Orens JB, Becker FS, Whyte RI, Rubin JM, et al. Endobronchial ultrasound-guided needle aspiration of mediastinal adenopathy. Am J Respir Crit Care Med. 1996. 153:1424–1430.
17. Ernst A, Anantham D, Eberhardt R, Krasnik M, Herth FJ. Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy. J Thorac Oncol. 2008. 3:577–582.
18. Hwangbo B, Lee GK, Lee HS, Lim KY, Lee SH, Kim HY, et al. Transbronchial and transesophageal fine-needle aspiration using an ultrasound bronchoscope in mediastinal staging of potentially operable lung cancer. Chest. 2010. 138:795–802.
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr